Press

Participation at the IASLC 2022 WCLC World Conference on Lung Cancer

TRACEPIGEN participant Milena Cavic attended the World Lung Cancer Congress (WCLC22) organized by the International Association for the Study of Lung Cancer (IASLC) in Vienna, Austria, August 5-9, 2022. WCLC22 is traditionally the world’s largest international gathering of clinicians, researchers and scientists in the field of lung cancer and thoracic oncology. The congress covered a …

Participation at the IASLC 2022 WCLC World Conference on Lung Cancer Read More »

Lungs with cancerous changes floating inside jar with formaldehyde in morgue

Lung cancer in Serbia

Lung cancer in Serbia Scientists at IORS, supported by the Science Fund of the Republic of Serbia, in collaboration with the Institute for Pulmonary Diseases of Vojvodina and the Pulmonary Diseases Clinic, University Clinical Center Nis have provided an up-to-date overview of the current epidemiological situation concerning lung cancer in Serbia published by Cavic et al. …

Lung cancer in Serbia Read More »

The right tool for the job: Benchmarking kits for DNA methylome analysis

Scientists at IORS, supported by the Science Fund of the Republic of Serbia, in collaboration with Beck lab at UCL Cancer Institute have performed a systematic benchmarking of sequencing-based methods for measuring DNA methylation and developed a framework for data integration across different platforms in a paper published by Tanić et al. in Nature Biotechnology. Epigenetics …

The right tool for the job: Benchmarking kits for DNA methylome analysis Read More »

Liquid Biopsy Workshop

Training the new generation of scientists in the hot topic of liquid biopsy biomarkers. TRACEPIGEN project will co-organize the Training school for circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) in collaboration with COST Action TRANSCOLONCAN, the European Liquid Biopsy Academy, and the Danish National Research Center for ctDNA. The workshop will take place …

Liquid Biopsy Workshop Read More »

Scroll to Top